StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

Equities research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the stock.

China Pharma Stock Up 5.6 %

NYSE:CPHI opened at $0.21 on Friday. China Pharma has a 1-year low of $0.17 and a 1-year high of $0.69. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The business’s fifty day moving average price is $0.22 and its 200 day moving average price is $0.23.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.